Pharmacogenetics and Genomics · 2007 · 42 citations · 53 references
MedicineMolecular GeneticsOncologyCancer GeneticsCarcinogenesisMolecular OncologyCancer EtiologyEsophageal CancerSquamous Cell CarcinomaArachidonic Acid Metabolism GeneticsCancer Risk AssociationCase-control Study DesignGenetic PolymorphismsLogistic RegressionMetabolism Enzyme PolymorphismsMolecular Mechanisms Of CarcinogenesisMolecular Risk Markers
BACKGROUND: Aberrant arachidonic acid metabolism by 12-lipoxygenase (12-LOX) and cyclooxygenase-2 (COX-2) has been implicated in human carcinogenesis. Inherited polymorphisms in 12-LOX and COX-2 contributed to differential expression or activity of these enzymes might confer interindividual susceptibility to cancer. OBJECTIVE: To examine the functional significance of 12-LOX 261 Arg> Gln polymorphism and its association, alone and in combination with COX-2 -1195G > A and -765G > C polymorphisms, with risk of developing esophageal squamous cell carcinoma (ESCC). METHODS: The platelet 12-LOX activity was measured by quantifying 12-HETE in the lipoxygenation reaction. Genotypes of 12-LOX261Arg>Gln and COX-2 -1195G>A and -765G>C polymorphisms were determined in a case-control study consisting of 1026 patients and 1270 controls. Associations with the risk of ESCC were estimated by logistic regression. RESULTS: Subjects with the 12-LOX Gln/Gln genotype had higher platelet 12-LOX activity (mean+/-SEM nmol/mg/min) than those with the Arg/Arg genotype (0.405+/-0.047 [n=10] versus 0.136+/-0.022 [n=6]; P=0.001). Genotyping data showed that the 12-LOX Gln/Gln genotype was associated with increased risk of developing ESCC (odds ratio [OR]=1.42, 95% confidence interval [CI]=1.12-1.81), compared with the Arg/Arg genotype adjusted for sex, age, and smoking. An increased risk of ESCC was also associated with the COX-2 -1195GA (OR=1.34, 95% CI=1.08-1.68; P=0.008), -1195AA (OR=1.72, 95% CI=1.35-2.20; P=<0.001), and -765GC (OR=2.24, 95% CI=1.59-3.16; P<0.001) genotypes. Furthermore, a multiplicative interaction between the 12-LOX Gln/Gln and COX-2 -1195AA or -765GC genotype in intensifying risk of ESCC was observed, with the ORs for the presence of both 12-LOX Gln/Gln and COX-2 -1195AA or -765GC genotypes being 3.21 (95% CI=1.93-5.34) and 3.33 (95% CI=1.59-6.98). A multiplicative interaction between the -765GC genotype and smoking was also evident (OR=4.45, 95% CI=2.71-7.29). CONCLUSION: These observations suggest that inherited polymorphisms in arachidonic acid-metabolizing enzymes, which result in heightened gene expression or enzymatic activity, may confer host susceptibility to ESCC.
53
Major Causes of Death among Men and Women in China
Jiang He, Dongfeng Gu, Xigui Wu et al. · New England Journal of Medicine · 2005 · 1.2K citations
Public Health, Geriatric Medicine, Population Health Sciences +17
Cyclooxygenase-2 expression in human esophageal carcinoma.
Katja Zimmermann, Mario Sarbia, Artur‐Aron Weber et al. · PubMed · 1999 · 669 citations
Medicine, Oncology, Pharmacology +12
Jingyuan Li, Philip R. Taylor, Bin Li et al. · JNCI Journal of the National Cancer Institute · 1993 · 428 citations